To answer Dr.PathRoch's question specifically:
From a clinical standpoint, Hydration tracking on GLP-1 is well-supported by the literature.
The short answer: follow the standard titration protocol and reassess at 4-6 weeks.
The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.